Eric Swanson, MD
Anatomic Pathology & Clinical Pathology · Salt Lake City, UTNPI 1548580756
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (54.1%), speaking fees and education — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by AstraZeneca at 46.9% of the total. Reporting peaked in 2019 at $882 and has fallen 72.9% since, to $239 in 2024.
Across 26 payments — averaging $62.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$761
- Blueprint Medicines Corporation$244
- Johnson & Johnson$164
- Merck$163
- Bayer$63
- AMAG Pharmaceuticals, Inc.$45
- plus $184 from 8 others
What the payments were for
- Speaking & faculty fees$70043%
- Food & beverage$87954%
- Education$453%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 4 | $761 |
| Blueprint Medicines Corporation | 2 | $244 |
| Johnson & Johnson(2 entities) | 3 | $164 |
| Merck | 3 | $163 |
| Bayer | 3 | $63 |
| AMAG Pharmaceuticals, Inc. | 2 | $45 |
| Eisai Inc. | 2 | $41 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Taiho Oncology, Inc. | 1 | $23 |
| Exelixis Inc. | 1 | $22 |
| Genentech USA, Inc. | 1 | $21 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $18 |
| Bristol Myers Squibb | 1 | $16 |
| Sanofi | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,624 in reported general payments places this provider in the 85th percentile of 57 anatomic pathology & clinical pathology providers in Utah.
See all anatomic pathology & clinical pathology providers in Utah →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anatomic pathology & clinical pathology in Salt Lake City
- Philip BernardSalt Lake City$268K
- Tracy GeorgeSalt Lake City$134K
- Benjamin BradleySalt Lake City$12K
- Anthony CretaraSalt Lake City$5K
- Barbara ChadwickSalt Lake City$3K
- Diping WangSalt Lake City$2K
- Evan RapsSalt Lake City$2K
- Rong MaoSalt Lake City$531
- Andrew HansenSalt Lake City$337
- Yahya DaneshbodSalt Lake City$310
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.